ZNF29P

Across TCGA pan-cancer cohorts, ZNF29P RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of ZNF29P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where ZNF29P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ZNF29P is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

KIRC, LUSC, and THCA are the cancer types where ZNF29P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ZNF29P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	IV	+0.292	.001	8	view →
LUSC	All	All	+0.227	.011	4	view →
THCA	All	All	−0.161	.026	2	view →
STAD	All	All	+0.392	.028	1	view →
CHOL	All	All	+0.365	.015	1	view →
HNSC	Female	IV	+0.343	.022	1	view →
LUAD	All	All	+0.279	.020	1	view →
KICH	Male	III,IV	+0.200	.034	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

ZNF29P–KIRC

Open the KIRC breakdown →